~(211)At偶联CEA单克隆抗体的标记及初步动物实验

LABELLING CEA-McAb WITH ~(211)At AND ITS PRELIMINARY ANIMAL EXPERIMENT

摘要: 以砹苯甲酸为中间体,通过活化羧基反应,制得了~(221)At偶联癌胚抗原(CEA)单克隆抗体(McAb)。改进了文献报道的方法,并采用HPLC对偶联物进行了分析和鉴定。方法全程标记率不低于30％,经凝胶色谱Sephadex G_(75)柱分离得到的偶联物注射液比活度可达3.7×10~4Bq/μg McAb。通过测定~(211)At-CEA McAb和~(211)At-在鼠血液和其它组织中的动态曲线,还讨论了偶联物在动物体内代谢的稳定性。
- ~211At /
- McAb /
- 间接标记法 /
- HPLC
Abstract: The synthesis of 211At labelled CEA monoclone antibody is performed by an activating reaction of carboxy via para-astato-benzoic interaction. The 211At-CEA-McAb conjugate is separated by a sephadex G75 column and then analysed and identified by hydrophobic interaction HPLC. It contains at least 30% of initial activity of 211At with the specific radioactivity, up to 3. 7×104 Bq/μg McAb. The stability in vivo of the conjugate is discussed by determining dynamic curve in mouse blood and other tissues.
- 211At /
- McAb /
- Indirect Labelling /
- HPLC.

[1]	Hofer K G. Bull Cancer (Paris), 1980,67: 343．
[2]	Brown I. Int J Appl Radiat Isot, 1986,37: 789．
[3]	王喜忠,等.大自然,1988,7:79．
[4]	Meyer G J, et al. Labelled Compd Radiopharm, 1976, 12: 449．
[5]	Smit J A, et al. CLin Exp Immunol,1973,14:107．
[6]	Aaij C, et al. J Appl Radiat Isot, 1975,26:25．
[7]	Visser G W M, et al. Int J Appl Radiat Isot, 1981,32:913．
[8]	Vaughan A T M, et al. Int J Nucl Biol, 1978,5:229．
[9]	Friedman A M, et al. Int J Appl Med Biol,1977,4:219．
[10]	Vaughan A T, M, et al. Int J Appl Radiat Isot, 1979,30: 576．
[11]	Harrison A, et al. Int J Appl Radiat Isot, 1984,35: 1005．
[12]	弋昌厚,金建南,张叔渊,等.同位素,1988,1:15．
[13]	周懋伦,等.四川大学学报(自然科学版),1986,3:8．
[14]	张叔渊.等.~(211) At标记CEA-McAb的HPLC分析鉴定和分离纯化研究,四川省放射化学与化工及同位素学术讨论会文集,成都,1989年,11月.
[15]	Spiegelberg H L, et al. J Exp Med, 1965, 121:323．
[16]	Brown I,et al. Int J Appl Radiat Isot,1984,35:843．